Eprotirome Completed Phase 2 Trials for Dyslipidemias Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00593047LDL-Cholesterol Lowering Effect of KB2115 as Add on to Statin